Previous studies have reported diverse genomic breakpoints of ALK rearrangements that occur in different regions (introns or exons) in NSCLC, and intronic breakpoint fusions usually result in in‐frame chimeric fusion transcripts/proteins [15, 18]. The gene discussed is ALK; the disease is non-small cell lung carcinoma.